GSK-GLP112757

Study Sponsor: GSK

Study Title

A Randomized, Double-blind, Placebo and Active-Controlled, Parallel-group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and with Metformin plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Medicine or Vaccine (generic name)

albiglutide

Sponsor Identification Number

GLP112757

Trial Registry Identification Number(#'s)

NCT00839527 2008-007664-42

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=112757

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00839527

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2008-007664-42

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format

Date Added to this Site

May 2015